Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
Recruiting · NCT06431919 · Registry updated 2025-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival | Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Left Ventricular Diastolic Dysfunction, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Ventricular Dysfunction, Ventricular Dysfunction, Left, acute kidney injury, cardiovascular disorder, cirrhosis of liver, cirrhotic cardiomyopathy, heart disorder, kidney disorder, kidney failure, liver disorder, urinary system disorder | Recruiting | Not applicable | 2025-06-08 | NCT06431919 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Indian Council of Medical Research | 29 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 43 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| PGIMER, Department of Hepatology | Chandigarh | India | 1 |